Document is current
Any future updates will be listed below
-
Authors
Yang, Bao-Zhu https://orcid.org/0000-0001-8506-6946
He, Li
Liu, Tie-Qiao
Ma, Shuangge
Wu, Yung-Fu
Wen, Li
Emu, Brinda
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse (R03DA047562)
U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse (R21DA061372)
U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (R01DK12689)
U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (R01DK130318)
- License Information
-
More Information
Article History
Received: 11 November 2025
Revised: 27 March 2026
Accepted: 30 March 2026
First Online: 15 April 2026
Competing interests
: The authors declare no conflicts of interest pertaining to this study, except for BE, who is a consultant for Genentech, Roche, Gilead, and Theratechnologies. None of these represents conflicts of interest for this manuscript.
